Skip to main content
PMC home page
Postgraduate Medical Journal logoLink to Postgraduate Medical Journal
. 1993 Aug;69(814):602–608. doi: 10.1136/pgmj.69.814.602

Current concepts of neuropsychiatric systemic lupus erythematosus (NP-SLE).

R A Asherson 1, S D Denburg 1, J A Denburg 1, R M Carbotte 1, N Futrell 1
PMCID: PMC2399680  PMID: 8234102

Full text

PDF
603

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abramsky O., Lisak R. P., Silberberg D. H., Pleasure D. E. Antibodies to oligodendroglia in patients with multiple sclerosis. N Engl J Med. 1977 Dec 1;297(22):1207–1211. doi: 10.1056/NEJM197712012972204. [DOI] [PubMed] [Google Scholar]
  2. Adelman D. C., Saltiel E., Klinenberg J. R. The neuropsychiatric manifestations of systemic lupus erythematosus: an overview. Semin Arthritis Rheum. 1986 Feb;15(3):185–199. doi: 10.1016/0049-0172(86)90016-8. [DOI] [PubMed] [Google Scholar]
  3. Anderson D., Bell D., Lodge R., Grant E. Recurrent cerebral ischemia and mitral valve vegetation in a patient with antiphospholipid antibodies. J Rheumatol. 1987 Aug;14(4):839–841. [PubMed] [Google Scholar]
  4. Asherson R. A., Derksen R. H., Harris E. N., Bouma B. N., Gharavi A. E., Kater L., Hughes G. R. Chorea in systemic lupus erythematosus and "lupus-like" disease: association with antiphospholipid antibodies. Semin Arthritis Rheum. 1987 May;16(4):253–259. doi: 10.1016/0049-0172(87)90003-5. [DOI] [PubMed] [Google Scholar]
  5. Asherson R. A., Khamashta M. A., Gil A., Vazquez J. J., Chan O., Baguley E., Hughes G. R. Cerebrovascular disease and antiphospholipid antibodies in systemic lupus erythematosus, lupus-like disease, and the primary antiphospholipid syndrome. Am J Med. 1989 Apr;86(4):391–399. doi: 10.1016/0002-9343(89)90335-5. [DOI] [PubMed] [Google Scholar]
  6. Asherson R. A., Lubbe W. F. Cerebral and valve lesions in SLE: association with antiphospholipid antibodies. J Rheumatol. 1988 Apr;15(4):539–543. [PubMed] [Google Scholar]
  7. Asherson R. A., Mercey D., Phillips G., Sheehan N., Gharavi A. E., Harris E. N., Hughes G. R. Recurrent stroke and multi-infarct dementia in systemic lupus erythematosus: association with antiphospholipid antibodies. Ann Rheum Dis. 1987 Aug;46(8):605–611. doi: 10.1136/ard.46.8.605. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Awada H. H., Mamo H. L., Luft A. G., Ponsin J. C., Kahn M. F. Cerebral blood flow in systemic lupus erythematosus with and without central nervous system involvement. J Neurol Neurosurg Psychiatry. 1987 Dec;50(12):1597–1601. doi: 10.1136/jnnp.50.12.1597. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Bell C. L., Partington C., Robbins M., Graziano F., Turski P., Kornguth S. Magnetic resonance imaging of central nervous system lesions in patients with lupus erythematosus. Correlation with clinical remission and antineurofilament and anticardiolipin antibody titers. Arthritis Rheum. 1991 Apr;34(4):432–441. doi: 10.1002/art.1780340408. [DOI] [PubMed] [Google Scholar]
  10. Bennahum D. A., Messner R. P. Recent observations on central nervous system lupus erythematosus. Semin Arthritis Rheum. 1975 Feb;4(3):253–266. doi: 10.1016/0049-0172(75)90012-8. [DOI] [PubMed] [Google Scholar]
  11. Bonfa E., Golombek S. J., Kaufman L. D., Skelly S., Weissbach H., Brot N., Elkon K. B. Association between lupus psychosis and anti-ribosomal P protein antibodies. N Engl J Med. 1987 Jul 30;317(5):265–271. doi: 10.1056/NEJM198707303170503. [DOI] [PubMed] [Google Scholar]
  12. Bresnihan B., Grigor R. R., Hughes G. R. Lymphocytotoxic antibodies in systemic lupus erythematosus: their clinical significance. J Clin Pathol Suppl (R Coll Pathol) 1979;13:112–115. doi: 10.1136/jcp.s3-13.1.112. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Briley D. P., Coull B. M., Goodnight S. H., Jr Neurological disease associated with antiphospholipid antibodies. Ann Neurol. 1989 Mar;25(3):221–227. doi: 10.1002/ana.410250303. [DOI] [PubMed] [Google Scholar]
  14. Burnstein S. L., Janoff L., McCormick K. Neuropsychiatric involvement in systemic lupus erythematosus: case report and review of the literature. J Am Osteopath Assoc. 1987 Sep;87(9):626–631. [PubMed] [Google Scholar]
  15. Carbotte R. M., Denburg S. D., Denburg J. A., Nahmias C., Garnett E. S. Fluctuating cognitive abnormalities and cerebral glucose metabolism in neuropsychiatric systemic lupus erythematosus. J Neurol Neurosurg Psychiatry. 1992 Nov;55(11):1054–1059. doi: 10.1136/jnnp.55.11.1054. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Carbotte R. M., Denburg S. D., Denburg J. A. Prevalence of cognitive impairment in systemic lupus erythematosus. J Nerv Ment Dis. 1986 Jun;174(6):357–364. doi: 10.1097/00005053-198606000-00008. [DOI] [PubMed] [Google Scholar]
  17. Coull B. M., Bourdette D. N., Goodnight S. H., Jr, Briley D. P., Hart R. Multiple cerebral infarctions and dementia associated with anticardiolipin antibodies. Stroke. 1987 Nov-Dec;18(6):1107–1112. doi: 10.1161/01.str.18.6.1107. [DOI] [PubMed] [Google Scholar]
  18. D'Alton J. G., Preston D. N., Bormanis J., Green M. S., Kraag G. R. Multiple transient ischemic attacks, lupus anticoagulant and verrucous endocarditis. Stroke. 1985 May-Jun;16(3):512–514. doi: 10.1161/01.str.16.3.512. [DOI] [PubMed] [Google Scholar]
  19. DUBOIS E. L., TUFFANELLI D. L. CLINICAL MANIFESTATIONS OF SYSTEMIC LUPUS ERYTHEMATOSUS. COMPUTER ANALYSIS OF 520 CASES. JAMA. 1964 Oct 12;190:104–111. doi: 10.1001/jama.1964.03070150014003. [DOI] [PubMed] [Google Scholar]
  20. Dalgleish A. G., Beverley P. C., Clapham P. R., Crawford D. H., Greaves M. F., Weiss R. A. The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus. Nature. 1984 Dec 20;312(5996):763–767. doi: 10.1038/312763a0. [DOI] [PubMed] [Google Scholar]
  21. Denburg J. A., Carbotte R. M., Denburg S. D. Neuronal antibodies and cognitive function in systemic lupus erythematosus. Neurology. 1987 Mar;37(3):464–467. doi: 10.1212/wnl.37.3.464. [DOI] [PubMed] [Google Scholar]
  22. Denburg J. A., Temesvari P. The pathogenesis of neuropsychiatric lupus. Can Med Assoc J. 1983 Feb 1;128(3):257–260. [PMC free article] [PubMed] [Google Scholar]
  23. Denburg S. D., Carbotte R. M., Denburg J. A. Cognitive impairment in systemic lupus erythematosus: a neuropsychological study of individual and group deficits. J Clin Exp Neuropsychol. 1987 Aug;9(4):323–339. doi: 10.1080/01688638708405054. [DOI] [PubMed] [Google Scholar]
  24. Denburg S. D., Carbotte R. M., Long A. A., Denburg J. A. Neuropsychological correlates of serum lymphocytotoxic antibodies in systemic lupus erythematosus. Brain Behav Immun. 1988 Sep;2(3):222–234. doi: 10.1016/0889-1591(88)90024-4. [DOI] [PubMed] [Google Scholar]
  25. Denicoff K. D., Rubinow D. R., Papa M. Z., Simpson C., Seipp C. A., Lotze M. T., Chang A. E., Rosenstein D., Rosenberg S. A. The neuropsychiatric effects of treatment with interleukin-2 and lymphokine-activated killer cells. Ann Intern Med. 1987 Sep;107(3):293–300. doi: 10.7326/0003-4819-107-2-293. [DOI] [PubMed] [Google Scholar]
  26. Derksen R. H., van Dam A. P., Gmelig Meyling F. H., Bijlsma J. W., Smeenk R. J. A prospective study on antiribosomal P proteins in two cases of familial lupus and recurrent psychosis. Ann Rheum Dis. 1990 Oct;49(10):779–782. doi: 10.1136/ard.49.10.779. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Devinsky O., Petito C. K., Alonso D. R. Clinical and neuropathological findings in systemic lupus erythematosus: the role of vasculitis, heart emboli, and thrombotic thrombocytopenic purpura. Ann Neurol. 1988 Apr;23(4):380–384. doi: 10.1002/ana.410230411. [DOI] [PubMed] [Google Scholar]
  28. Endo T., Scott D. D., Stewart S. S., Kundu S. K., Marcus D. M. Antibodies to glycosphingolipids in patients with multiple sclerosis and SLE. J Immunol. 1984 Apr;132(4):1793–1797. [PubMed] [Google Scholar]
  29. Feinglass E. J., Arnett F. C., Dorsch C. A., Zizic T. M., Stevens M. B. Neuropsychiatric manifestations of systemic lupus erythematosus: diagnosis, clinical spectrum, and relationship to other features of the disease. Medicine (Baltimore) 1976 Jul;55(4):323–339. doi: 10.1097/00005792-197607000-00004. [DOI] [PubMed] [Google Scholar]
  30. Fields R. A., Sibbitt W. L., Toubbeh H., Bankhurst A. D. Neuropsychiatric lupus erythematosus, cerebral infarctions, and anticardiolipin antibodies. Ann Rheum Dis. 1990 Feb;49(2):114–117. doi: 10.1136/ard.49.2.114. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Frei K., Leist T. P., Meager A., Gallo P., Leppert D., Zinkernagel R. M., Fontana A. Production of B cell stimulatory factor-2 and interferon gamma in the central nervous system during viral meningitis and encephalitis. Evaluation in a murine model infection and in patients. J Exp Med. 1988 Jul 1;168(1):449–453. doi: 10.1084/jem.168.1.449. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Futrell N., Schultz L. R., Millikan C. Central nervous system disease in patients with systemic lupus erythematosus. Neurology. 1992 Sep;42(9):1649–1657. doi: 10.1212/wnl.42.9.1649. [DOI] [PubMed] [Google Scholar]
  33. Gibson T., Myers A. R. Nervous system involvement in systemic lupus erythematosus. Ann Rheum Dis. 1975 Oct;35(5):398–406. doi: 10.1136/ard.35.5.398. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Ginsburg K. S., Wright E. A., Larson M. G., Fossel A. H., Albert M., Schur P. H., Liang M. H. A controlled study of the prevalence of cognitive dysfunction in randomly selected patients with systemic lupus erythematosus. Arthritis Rheum. 1992 Jul;35(7):776–782. doi: 10.1002/art.1780350711. [DOI] [PubMed] [Google Scholar]
  35. Hanly J. G., Fisk J. D., Sherwood G., Jones E., Jones J. V., Eastwood B. Cognitive impairment in patients with systemic lupus erythematosus. J Rheumatol. 1992 Apr;19(4):562–567. [PubMed] [Google Scholar]
  36. Hanly J. G., Rajaraman S., Behmann S., Denburg J. A. A novel neuronal antigen identified by sera from patients with systemic lupus erythematosus. Arthritis Rheum. 1988 Dec;31(12):1492–1499. doi: 10.1002/art.1780311205. [DOI] [PubMed] [Google Scholar]
  37. Hay E. M., Black D., Huddy A., Creed F., Tomenson B., Bernstein R. M., Holt P. J. Psychiatric disorder and cognitive impairment in systemic lupus erythematosus. Arthritis Rheum. 1992 Apr;35(4):411–416. doi: 10.1002/art.1780350409. [DOI] [PubMed] [Google Scholar]
  38. Hiraiwa M., Nonaka C., Abe T., Iio M. Positron emission tomography in systemic lupus erythematosus: relation of cerebral vasculitis to PET findings. AJNR Am J Neuroradiol. 1983 May-Jun;4(3):541–543. [PMC free article] [PubMed] [Google Scholar]
  39. Hirano T., Hashimoto H., Shiokawa Y., Iwamori M., Nagai Y., Kasai M., Ochiai Y., Okumura K. Antiglycolipid autoantibody detected in the sera from systemic lupus erythematosus patients. J Clin Invest. 1980 Dec;66(6):1437–1440. doi: 10.1172/JCI109999. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Hirohata S., Miyamoto T. Elevated levels of interleukin-6 in cerebrospinal fluid from patients with systemic lupus erythematosus and central nervous system involvement. Arthritis Rheum. 1990 May;33(5):644–649. doi: 10.1002/art.1780330506. [DOI] [PubMed] [Google Scholar]
  41. Houssiau F. A., Bukasa K., Sindic C. J., Van Damme J., Van Snick J. Elevated levels of the 26K human hybridoma growth factor (interleukin 6) in cerebrospinal fluid of patients with acute infection of the central nervous system. Clin Exp Immunol. 1988 Feb;71(2):320–323. [PMC free article] [PubMed] [Google Scholar]
  42. How A., Dent P. B., Liao S. K., Denburg J. A. Antineuronal antibodies in neuropsychiatric systemic lupus erythematosus. Arthritis Rheum. 1985 Jul;28(7):789–795. doi: 10.1002/art.1780280710. [DOI] [PubMed] [Google Scholar]
  43. Johnson R. T., Richardson E. P. The neurological manifestations of systemic lupus erythematosus. Medicine (Baltimore) 1968 Jul;47(4):337–369. doi: 10.1097/00005792-196807000-00002. [DOI] [PubMed] [Google Scholar]
  44. Kelly M. C., Denburg J. A. Cerebrospinal fluid immunoglobulins and neuronal antibodies in neuropsychiatric systemic lupus erythematosus and related conditions. J Rheumatol. 1987 Aug;14(4):740–744. [PubMed] [Google Scholar]
  45. Kopelman R. G., Zolla-Pazner S. Association of human immunodeficiency virus infection and autoimmune phenomena. Am J Med. 1988 Jan;84(1):82–88. doi: 10.1016/0002-9343(88)90012-5. [DOI] [PubMed] [Google Scholar]
  46. Kremer J. M., Rynes R. I., Bartholomew L. E., Rodichok L. D., Pelton E. W., Block E. A., Tassinari R. B., Silver R. J. Non-organic non-psychotic psychopathology (NONPP) in patients with systemic lupus erythematosus. Semin Arthritis Rheum. 1981 Aug;11(1):182–189. doi: 10.1016/0049-0172(81)90099-8. [DOI] [PubMed] [Google Scholar]
  47. Kushner M. J., Chawluk J., Fazekas F., Mandell B., Burke A., Jaggi J., Rosen M., Reivich M. Cerebral blood flow in systemic lupus erythematosus with or without cerebral complications. Neurology. 1987 Oct;37(10):1596–1598. doi: 10.1212/wnl.37.10.1596. [DOI] [PubMed] [Google Scholar]
  48. Kushner M., Simonian N. Lupus anticoagulants, anticardiolipin antibodies, and cerebral ischemia. Stroke. 1989 Feb;20(2):225–229. doi: 10.1161/01.str.20.2.225. [DOI] [PubMed] [Google Scholar]
  49. LIDZ T., CARTER J. D., LEWIS B. I., SURRATT C. Effects of ACTH and cortisone on mood and mentation. Psychosom Med. 1952 Sep-Oct;14(5):363–377. doi: 10.1097/00006842-195209000-00003. [DOI] [PubMed] [Google Scholar]
  50. Levine S. R., Deegan M. J., Futrell N., Welch K. M. Cerebrovascular and neurologic disease associated with antiphospholipid antibodies: 48 cases. Neurology. 1990 Aug;40(8):1181–1189. doi: 10.1212/wnl.40.8.1181. [DOI] [PubMed] [Google Scholar]
  51. Liang M. H., Rogers M., Larson M., Eaton H. M., Murawski B. J., Taylor J. E., Swafford J., Schur P. H. The psychosocial impact of systemic lupus erythematosus and rheumatoid arthritis. Arthritis Rheum. 1984 Jan;27(1):13–19. doi: 10.1002/art.1780270102. [DOI] [PubMed] [Google Scholar]
  52. Liang M. H., Socher S. A., Larson M. G., Schur P. H. Reliability and validity of six systems for the clinical assessment of disease activity in systemic lupus erythematosus. Arthritis Rheum. 1989 Sep;32(9):1107–1118. doi: 10.1002/anr.1780320909. [DOI] [PubMed] [Google Scholar]
  53. Ling M. H., Perry P. J., Tsuang M. T. Side effects of corticosteroid therapy. Psychiatric aspects. Arch Gen Psychiatry. 1981 Apr;38(4):471–477. doi: 10.1001/archpsyc.1981.01780290105011. [DOI] [PubMed] [Google Scholar]
  54. Long A. A., Denburg S. D., Carbotte R. M., Singal D. P., Denburg J. A. Serum lymphocytotoxic antibodies and neurocognitive function in systemic lupus erythematosus. Ann Rheum Dis. 1990 Apr;49(4):249–253. doi: 10.1136/ard.49.4.249. [DOI] [PMC free article] [PubMed] [Google Scholar]
  55. Mackworth-Young C. G., Hughes G. R. Epilepsy: an early symptom of systemic lupus erythematosus. J Neurol Neurosurg Psychiatry. 1985 Feb;48(2):185–185. doi: 10.1136/jnnp.48.2.185. [DOI] [PMC free article] [PubMed] [Google Scholar]
  56. McCune W. J., Golbus J. Neuropsychiatric lupus. Rheum Dis Clin North Am. 1988 Apr;14(1):149–167. [PubMed] [Google Scholar]
  57. McCune W. J., MacGuire A., Aisen A., Gebarski S. Identification of brain lesions in neuropsychiatric systemic lupus erythematosus by magnetic resonance scanning. Arthritis Rheum. 1988 Feb;31(2):159–166. doi: 10.1002/art.1780310202. [DOI] [PubMed] [Google Scholar]
  58. McGarry R. C., Helfand S. L., Quarles R. H., Roder J. C. Recognition of myelin-associated glycoprotein by the monoclonal antibody HNK-1. Nature. 1983 Nov 24;306(5941):376–378. doi: 10.1038/306376a0. [DOI] [PubMed] [Google Scholar]
  59. Minden S. L., Moes E. J., Orav J., Kaplan E., Reich P. Memory impairment in multiple sclerosis. J Clin Exp Neuropsychol. 1990 Aug;12(4):566–586. doi: 10.1080/01688639008401002. [DOI] [PubMed] [Google Scholar]
  60. Minota S., Winfield J. B. Identification of three major target molecules of IgM antilymphocyte autoantibodies in systemic lupus erythematosus. J Immunol. 1987 Dec 1;139(11):3644–3651. [PubMed] [Google Scholar]
  61. Minota S., Winfield J. B. IgG anti-lymphocyte antibodies in systemic lupus erythematosus react with surface molecules shared by peripheral T cells and a primitive T cell line. J Immunol. 1987 Mar 15;138(6):1750–1756. [PubMed] [Google Scholar]
  62. Minota S., Winfield J. B. Nature of IgG anti-lymphocyte autoantibody-reactive molecules shed from activated T cells in systemic lupus erythematosus. Rheumatol Int. 1988;8(4):165–170. doi: 10.1007/BF00270455. [DOI] [PubMed] [Google Scholar]
  63. O'Connor J. F., Musher D. M. Central nervous system involvement in systemic lupus erythematosus. A study of 150 cases. Arch Neurol. 1966 Feb;14(2):157–164. doi: 10.1001/archneur.1966.00470080041006. [DOI] [PubMed] [Google Scholar]
  64. O'Connor P. Diagnosis of central nervous system lupus. Can J Neurol Sci. 1988 Aug;15(3):257–260. doi: 10.1017/s0317167100027700. [DOI] [PubMed] [Google Scholar]
  65. Omdal R., Mellgren S. I., Husby G. Clinical neuropsychiatric and neuromuscular manifestations in systemic lupus erythematosus. Scand J Rheumatol. 1988;17(2):113–117. doi: 10.3109/03009748809098770. [DOI] [PubMed] [Google Scholar]
  66. Papero P. H., Bluestein H. G., White P., Lipnick R. N. Neuropsychologic deficits and antineuronal antibodies in pediatric systemic lupus erythematosus. Clin Exp Rheumatol. 1990 Jul-Aug;8(4):417–424. [PubMed] [Google Scholar]
  67. Pinching A. J., Travers R. L., Hughes G. R., Jones T., Moss S. Oxygen-15 brain scanning for detection of cerebral involvement in systemic lupus erythematosus. Lancet. 1978 Apr 29;1(8070):898–900. doi: 10.1016/s0140-6736(78)90680-3. [DOI] [PubMed] [Google Scholar]
  68. Price R. W., Brew B. Infection of the central nervous system by human immunodeficiency virus. Role of the immune system in pathogenesis. Ann N Y Acad Sci. 1988;540:162–175. doi: 10.1111/j.1749-6632.1988.tb27059.x. [DOI] [PubMed] [Google Scholar]
  69. Query C. C., Keene J. D. A human autoimmune protein associated with U1 RNA contains a region of homology that is cross-reactive with retroviral p30gag antigen. Cell. 1987 Oct 23;51(2):211–220. doi: 10.1016/0092-8674(87)90148-6. [DOI] [PubMed] [Google Scholar]
  70. REIF A. E., ALLEN J. M. THE AKR THYMIC ANTIGEN AND ITS DISTRIBUTION IN LEUKEMIAS AND NERVOUS TISSUES. J Exp Med. 1964 Sep 1;120:413–433. doi: 10.1084/jem.120.3.413. [DOI] [PMC free article] [PubMed] [Google Scholar]
  71. Rao S. M., Leo G. J., St Aubin-Faubert P. On the nature of memory disturbance in multiple sclerosis. J Clin Exp Neuropsychol. 1989 Oct;11(5):699–712. doi: 10.1080/01688638908400926. [DOI] [PubMed] [Google Scholar]
  72. Ricciardi-Castagnoli P., Pirami L., Righi M., Sacerdote P., Locatelli V., Bianchi M., Sassano M., Valsasnini P., Shammah S., Panerai A. E. Cellular sources and effects of tumor necrosis factor-alpha on pituitary cells and in the central nervous system. Ann N Y Acad Sci. 1990;594:156–168. doi: 10.1111/j.1749-6632.1990.tb40476.x. [DOI] [PubMed] [Google Scholar]
  73. Sakić B., Szechtman H., Keffer M., Talangbayan H., Stead R., Denburg J. A. A behavioral profile of autoimmune lupus-prone MRL mice. Brain Behav Immun. 1992 Sep;6(3):265–285. doi: 10.1016/0889-1591(92)90048-s. [DOI] [PubMed] [Google Scholar]
  74. Schneebaum A. B., Singleton J. D., West S. G., Blodgett J. K., Allen L. G., Cheronis J. C., Kotzin B. L. Association of psychiatric manifestations with antibodies to ribosomal P proteins in systemic lupus erythematosus. Am J Med. 1991 Jan;90(1):54–62. doi: 10.1016/0002-9343(91)90506-s. [DOI] [PubMed] [Google Scholar]
  75. Sibbitt W. L., Jr, Sibbitt R. R., Griffey R. H., Eckel C., Bankhurst A. D. Magnetic resonance and computed tomographic imaging in the evaluation of acute neuropsychiatric disease in systemic lupus erythematosus. Ann Rheum Dis. 1989 Dec;48(12):1014–1022. doi: 10.1136/ard.48.12.1014. [DOI] [PMC free article] [PubMed] [Google Scholar]
  76. Singh V. K., Fudenberg H. H. Can blood immunocytes be used to study neuropsychiatric disorders? J Clin Psychiatry. 1986 Dec;47(12):592–595. [PubMed] [Google Scholar]
  77. Steinberg A. D., Klinman D. M. Pathogenesis of systemic lupus erythematosus. Rheum Dis Clin North Am. 1988 Apr;14(1):25–41. [PubMed] [Google Scholar]
  78. Stoppe G., Wildhagen K., Seidel J. W., Meyer G. J., Schober O., Heintz P., Künkel H., Deicher H., Hundeshagen H. Positron emission tomography in neuropsychiatric lupus erythematosus. Neurology. 1990 Feb;40(2):304–308. doi: 10.1212/wnl.40.2.304. [DOI] [PubMed] [Google Scholar]
  79. Temesvari P., Denburg J., Denburg S., Carbotte R., Bensen W., Singal D. Serum lymphocytotoxic antibodies in neuropsychiatric lupus: a serial study. Clin Immunol Immunopathol. 1983 Aug;28(2):243–251. doi: 10.1016/0090-1229(83)90158-7. [DOI] [PubMed] [Google Scholar]
  80. Teplizki H., Buskila D., Argov S., Isenberg D., Coates A. R., Sukenik S., Horowitz J., Shoenfeld Y. Low serum antimycobacterial glycolipid antibody titers in the sera of patients with systemic lupus erythematosus associated with central nervous system involvement. J Rheumatol. 1987 Jun;14(3):507–511. [PubMed] [Google Scholar]
  81. Urowitz M. B., Gladman D. D., Tozman E. C., Goldsmith C. H. The lupus activity criteria count (LACC). J Rheumatol. 1984 Dec;11(6):783–787. [PubMed] [Google Scholar]
  82. Volkow N. D., Warner N., McIntyre R., Valentine A., Kulkarni M., Mullani N., Gould L. Cerebral involvement in systemic lupus erythematosus. Am J Physiol Imaging. 1988;3(2):91–98. [PubMed] [Google Scholar]
  83. Waage A., Brandtzaeg P., Halstensen A., Kierulf P., Espevik T. The complex pattern of cytokines in serum from patients with meningococcal septic shock. Association between interleukin 6, interleukin 1, and fatal outcome. J Exp Med. 1989 Jan 1;169(1):333–338. doi: 10.1084/jem.169.1.333. [DOI] [PMC free article] [PubMed] [Google Scholar]
  84. Ward M. M., Studenski S. The time course of acute psychiatric episodes in systemic lupus erythematosus. J Rheumatol. 1991 Apr;18(4):535–539. [PubMed] [Google Scholar]
  85. Winfield J. B. Anti-lymphocyte antibodies in systemic lupus erythematosus. Clin Rheum Dis. 1985 Dec;11(3):523–549. [PubMed] [Google Scholar]
  86. Wong K. L., Woo E. K., Yu Y. L., Wong R. W. Neurological manifestations of systemic lupus erythematosus: a prospective study. Q J Med. 1991 Oct;81(294):857–870. [PubMed] [Google Scholar]
  87. Ziegler J. L., Stites D. P. Hypothesis: AIDS is an autoimmune disease directed at the immune system and triggered by a lymphotropic retrovirus. Clin Immunol Immunopathol. 1986 Dec;41(3):305–313. doi: 10.1016/0090-1229(86)90001-2. [DOI] [PubMed] [Google Scholar]

Articles from Postgraduate Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES